Abstract
Increasing number of data suggests that locally produced histamine is involved in regulation of hematopoiesis. In this study the granulocyte/macrophage (CFU-GM) colony formation by normal murine or human bone marrow cells, leukaemic colony formation (CFU-L) by a murine leukemia cell line (WEHI 3B), and colony formation by bone marrow cells from patients with chronic myeloid leukemia (CML) have been examined. We detected mRNA and protein expression of histidine decarboxylase (HDC), the only enzyme responsible for histamine synthesis both in normal bone marrow progenitor cells and in leukaemic progenitors. The significance of in situ generated histamine was shown on colony formation by inhibitory action of αFMH (blocking HDC activity, i.e. de novo histamine formation) and by N,N-diethyl-2-{4-(phenylmethyl)phenoxy|-ethanamine-HCl (DPPE) disturbing the interference of histamine with intracellular binding sites. These data provide further confirmation of the role of histamine in development and colony formation of bone marrow derived cells.
Article PDF
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
References
Bencsáth, M., Gidáli, J., Szeberényi, J., Hegyi, K., Falus, A. (2000) Regulation of murine hematopoietic colony formation by histamine. Inflamm. Res, 49 Suppl 1, S. 66–67.
Brandes, L. J., Beecroft, W. A., Hogg, G. R. (1991) Stimulation of in vivo tumor growth and phorbol ester-induced inflammation by N,N-diethyl-2(phenylmethyl)phenoxyethanamine HCl, a potent lig-and for intracellular histamine receptors. Biochem. Biophys. Res. Commun. 179, 1297–1304.
Brandes, L. J., Queen, G. M., LaBella, F. S. (1998) Potent interaction of histamine and polyamines at microsomal P450, nuclei and chromatin from rat hepatocytes. J. Cell. Biochem. 69, 233–243.
Brandes, L. J., Quenn, G. M., LaBella, F. S. (1999) N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE), a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isoenzymes that metabolize antineoplastic drugs. Cancer Chemother. Pharmacol. (in press)
Byron, J. W. (1977) Mechanism for histamine H2-receptor induced cell-cycle changes in the bone marrow stem cells. Agents Actions 7, 209.
Corbel, S., Schneider, E., Lemoine, F. M., Dy, M. (1995) Murine hematopoietic progenitors are capable of both histamine synthesis and uptake. Bloo. 86, 531–539.
Corbel, S., Dy, M. (1996) Evidence for bidirectional histamine transport by murine hematopoietic progenitor cells. FEBS Lett. 391, 279–281.
Dy, M., Machavoine, F., Lebel, B., Ichikawa, A., Gastinel, L. N., Schneider, E. (1993) Interleukin 3 promotes histamine synthesis in hematopoietic progenitors by increasing histidine decarboxylase mRNA expression. Biochem. Biophys. Res. Commun. 192, 167–173.
Glavin, G. B., Gerrard, J. M. (1990) Characterization of the gastroprotective effects of N,N-diethyl-2-(4-(phenylmethyl)phenoxy)-ethanamine hydrochloride, a non-H1/non-H2 histamine antagonist. Digestio. 47, 143–148.
Gricco, G. P., Davio, C. A., Martin, G., Engel, N., Fitzsimons, C. P., Bergoc, R. M., Rivera, E. S. (1994) Histamine as an autocrine growth factor in experimental mammary carcinomas. Agents Action. 43, 17–20.
Haak-Frendscho, M., Darvas, D., Hegyesi, H., Kárpáti, S., Hoffman, R. L., László, V. L., Bencsáth, M., Szalai, C., Fürész, J., Timar, J., Kemeny, L., Bata-Csorgo, Zs., Szabad, G., Pivarcsi, A., Pállinger, E., Horváth, A., Dobozy, A., Falus, A. (2000) Histidine decarboxylase expression in human melanoma. J. Invest. Dermatol. 115, 345–352.
Hoefakker, S., Boersma, W. J. A., Claassen, E. (1995) Detection of human cytokines in situ using antibody and probe based methods. J. Immunol. Method. 185, 149–175.
Kollonitsch, J., Ptchett, A. A., Marburg, S., Perkins, L. M., Doldouras, G. A., Duggan, D. E., Aster, S. D. (1978) Selective inhibitors of biosynthesis of aminergic neurotransmitters. Natur. 274, 906–908.
LaBella, F. S., Brandes, L. J. (1996) Enhancement of tumor growth by drugs with some common molecular actions. Molecular Carcinogenesi. 16, 68–76.
Piquet-Pellorce, C., Dy, M. (1991) Prostaglandin E2 potentiates granulocyte-macrophage colony stimulating factor-induced histamine synthesis in bone marrow cells: role of cAMP. Life Sci. 48, 2377–2382.
Piquet-Pellorce, C., Schneider, E., Dy, M. (1991) GM-CSF in association with IL-1 triggers day-8 CFU-S into cell cycle: role of histamine. J. Cell. Physiol. 149, 18–23.
Robinson, A. (1994) More questions than answers: antihistamines’ link to cancer. Can. Med. Assoc. J. 151, 797–801.
Schneider, E., Ploemacher, R. E., Nabarra, B., Brons, N. H. C., Dy, M. (1993) Mast cells and their committed precursors are not required for interleukin-3-induced histamine synthesis in murine bone marrow: characteristics of histamine-producing cells. Bloo. 81, 1161–1169.
Wang, L., Gantz, I., delValle, J. (1996) Histamine H2 receptor activates adenylate cyclase and PLC via separate GTP-dependent pathways. Am. J. Physiol. 271, G613–G620.
Watanabe, T., Yamatodani, A., Kazutaka, M., Wada, H. (1990) Pharmacology of α-fluoromethylhis-tidine, a specific inhibitor of histidine decarboxylase. TiP. 11, 363–367.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Bencsáth, M., Gidáli, J., Brandes, L.J. et al. Murine and Human Hematopoietic Colony Formation: A Possible Regulatory Role for Intracellular Histamine. BIOLOGIA FUTURA 53, 299–306 (2002). https://doi.org/10.1556/ABiol.53.2002.3.6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1556/ABiol.53.2002.3.6